NCT06764498

Brief Summary

Retrospective study to evaluate the effectiveness of the approach to enuresis at IRCCS Azienda Ospedaliero-Universitaria of Bologna Policlinico di Sant'Orsola, Italy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2022

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

January 2, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 8, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 8, 2025

Status Verified

December 1, 2024

Enrollment Period

3.9 years

First QC Date

January 2, 2025

Last Update Submit

January 2, 2025

Conditions

Keywords

EnuresisChildren

Outcome Measures

Primary Outcomes (3)

  • Daily urinary frequency

    increase (≥8 micturitions/day) or decrease (≤3 micturitions/day)

    at baseline

  • Maximum Voided Volume (MVV)

    volume of urine emitted in 24 hours, excluding first morning urine

    at baseline

  • Bladder capacity

    reduction (\<35% of expected bladder capacity) or increase (\> 150% of expected bladder capacity)

    at baseline

Eligibility Criteria

AgeUp to 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Since this is a descriptive study, a formal calculation of sample size is not expected. However, about 150-200 subjects are expected to be enrolled.

You may qualify if:

  • Patients of either sex under the age of 18 years at the time of the first outpatient visit;
  • Patients clinically evaluated in the outpatient clinic during the period 01/05/2019- 31/05/2021 with a diagnosis of enuresis;
  • Patients presenting at least two outpatient follow-ups;
  • Informed consent signed by parent or legal guardian.

You may not qualify if:

  • Patients older than 18 years of age;
  • Patients who lack completed night and daily diaries;
  • Patients with continuous incontinence;
  • Patients with neurological disorders and/or signs of spinal occult dysraphism;
  • Patients with a severe cognitive disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, 40138, Italy

Location

MeSH Terms

Conditions

Enuresis

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesBehavioral SymptomsBehaviorElimination DisordersMental Disorders

Study Officials

  • Andrea Pasini, MD

    IRCCS Azienda Ospedaliero-Universitaria di Bologna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2025

First Posted

January 8, 2025

Study Start

February 10, 2022

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

January 8, 2025

Record last verified: 2024-12

Locations